Clinical Outcomes Of A New Enhanced Intermediate Vision Iol (Precizon Go)
Published 2024 - 42nd Congress of the ESCRS
Reference: PP13.14 | Type: Free paper | DOI: 10.82333/zjrg-2x34
Authors: Daniel Velázquez Villoria* 1 , R Neuhann 2 , Eom Youngsub 3 , Im ChanYoung 4 , Lee Junhun 5 , Jeong Jiwon 6 , Adrian Gericke 7 , LUIS Salvá 8
1CLINICA VILLORIA,PONTEVEDRA,Spain, 2Eye Clinic Munich Ophthalmologikum Dr. Neuhann,MUNICH,Germany, 3Korea University College of Medicine, Ansan Hospital,Gyeonggi-do,Korea, Republic Of, 4Ian Eye Center,SEOUL,Korea, Republic Of, 5I-back Eye Clinic,SEOUL,Korea, Republic Of, 6Fatima Eye Clinic,SEOUL,Korea, Republic Of, 7University Medical Center Mainz,MAINZ,Germany, 8Clínica Oftalmedic Salvá,PALMA DE MALLORCA,Spain
Purpose
To evaluate the standard visual outcomes, including quality of vision and patient satisfaction, following standard cataract surgery with bilateral implantation of Precizon Go, developed by Ophtec, Groningen, NED.
Setting
Prospective non-comparative case series in seven centers in three countries.
Methods
This prospective non-comparative case series involved 64 eyes of 32 patients. The primary outcome measures included postoperative corrected/uncorrected visual acuity at far and intermediate distances of 80 and 66 cm (LogMAR). Manifest refraction spherical equivalent (MRSE) was assessed as a secondary outcome measure. Patient satisfaction and quality of vision were evaluated through a questionnaire. Follow-up assessments were conducted one month post-surgery.
Results
At 1 month post-surgery, MRSE significantly improved from +0.53 D ± 1.74 D to -0.12 D ± 0.30 D. Uncorrected distance visual acuity (UDVA) showed a notable enhancement, with mean values improving from 0.36 ± 0.21 to 0.04 ± 0.06 LogMAR. Distance corrected intermediate visual acuity (DCIVA) at 80 and 66 cm demonstrated satisfactory outcomes, with mean values of 0.14 ± 0.09 and 0.21 ± 0.07 LogMAR, respectively. Analysis of questionnaire data revealed that only 3% of patients experienced photic phenomena frequently, while 12% experienced them sometimes, and 85% reported never experiencing such phenomena. Moreover, 100% and 94% of patients expressed high levels of satisfaction with their far vision and intermediate vision, respectively
Conclusions
The Precizon Go IOL demonstrates excellent performance, yielding favorable outcomes and eliciting high levels of patient satisfaction at both far and intermediate distances. Additionally, patients reported minimal occurrence of photic phenomena.